SUGATAB® – M3/850 Tablet

SUGATAB® – M3/850 is a fixed-dose combination of Glimepiride, a sulfonylurea that stimulates insulin secretion, and Metformin, a first-line biguanide that enhances insulin sensitivity. It is formulated for patients with type 2 diabetes mellitus (T2DM) who require stronger glycemic control and are not adequately managed on lower-dose combinations or monotherapy. This higher-strength formulation supports HbA1c reduction, post-meal glucose control, and long-term diabetes management.

Categories: ,

Description

Composition (Each Film-Coated Tablet Contains):

  • Glimepiride – 3 mg

  • Metformin Hydrochloride – 850 mg

Category: Diabetes Care / Sulfonylurea + Biguanide Combination
Form: Oral Tablet
Pack Size: 10×10 Alu-Alu or Blister Pack


Product Description:

SUGATAB® – M3/850 is a fixed-dose combination of Glimepiride, a sulfonylurea that stimulates insulin secretion, and Metformin, a first-line biguanide that enhances insulin sensitivity. It is formulated for patients with type 2 diabetes mellitus (T2DM) who require stronger glycemic control and are not adequately managed on lower-dose combinations or monotherapy. This higher-strength formulation supports HbA1c reduction, post-meal glucose control, and long-term diabetes management.


Key Benefits:

  • Dual mechanism targets insulin resistance and secretion

  • High-strength dose for patients with moderate to advanced T2DM

  • Controls both fasting and postprandial blood sugar levels

  • Helps reduce HbA1c effectively with once-daily dosing

  • Cost-effective treatment with broad therapeutic reach


How it works:

  • Glimepiride stimulates insulin release from functional pancreatic beta cells in a glucose-dependent manner

  • Metformin reduces hepatic glucose production and improves peripheral insulin sensitivity, enhancing glucose uptake by muscles and fat

Together, they provide broad-spectrum glucose control throughout the day.


How to use:

  • Take one tablet once daily, preferably with breakfast or the first major meal

  • Swallow whole with water — do not split or chew

  • Dose should be individualized based on patient response and physician’s recommendation

  • Maintain a healthy lifestyle, diet, and exercise plan alongside medication


Safety Advice:

  • May cause hypoglycemia if meals are skipped — always eat after taking the tablet

  • Gastrointestinal discomfort (due to Metformin) may occur initially

  • Avoid alcohol to reduce risk of lactic acidosis and hypoglycemia

  • Regular monitoring of blood glucose, kidney function, and HbA1c is recommended


Precautions:

  • Not recommended in type 1 diabetes, diabetic ketoacidosis, or severe renal/hepatic impairment

  • Caution in elderly, debilitated, or malnourished patients

  • Not to be used during pregnancy or breastfeeding unless medically advised

  • Inform your doctor about all other antidiabetic or cardiovascular medications


Storage:

Store below 25°C in a dry place.
Keep away from direct sunlight and moisture.
Keep out of reach of children.

Reviews

There are no reviews yet.

Be the first to review “SUGATAB® – M3/850 Tablet”

Your email address will not be published. Required fields are marked *